Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and childrenCombination inhaled corticosteroids and long-acting beta 2 -agonists for children and adults with bronchiectasisRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse eventsRegular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsCombined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary diseaseAddition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and childrenAddition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthmaRegular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse eventsRegular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse eventsThe use of inhaled corticosteroids in pediatric asthma: updateLoss of asthma control in pediatric patients after discontinuation of long-acting Beta-agonistsCanadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults.Anti-asthma medication prescribing to children in the Lombardy Region of Italy: chronic versus new usersCurrent recommendations for the treatment of mild asthma.Childhood asthma management pre- and post-incident asthma hospitalization.Effects of a short course of inhaled corticosteroids in noneosinophilic asthmatic subjectsThe Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitationPragmatic research and outcomes in asthma and COPDOnce-daily fluticasone furoate alone or combined with vilanterol in persistent asthma.Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis.The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy.Bronchial reversibility with a short-acting β2-agonist predicts the FEV1 response to administration of a long-acting β2-agonist with inhaled corticosteroids in patients with bronchial asthma.A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma.
P2860
about
Q24194043-F84933A9-BA74-4FA6-9038-051B991A5EDEQ24200353-DB61DD32-4031-4F60-B733-8DF91F0172D0Q24201048-EDBBFCAC-6A4F-4A56-94D6-D3E9908719EDQ24202005-3AAE1100-D33F-47C8-9480-8CD534E3561EQ24202510-9DB304F2-D060-4D7E-BCDA-8B3A08B435EBQ24235303-0E59EF5C-F1B2-49D7-949D-3A806F3BA31DQ24235964-6B64389A-C6A8-4E49-89AC-89A5CA0ACB4EQ24240282-039790C1-FC39-4630-8941-28573CB874A9Q24240464-A71F614F-DBBC-4831-BB59-FCA3F48B4F66Q24240832-DD64E30C-E93C-45D9-A61C-325BA8658398Q26739763-D636D2A4-9890-4B7F-8D23-089C98CBCA56Q28388214-B1F7939E-54F5-403A-98E9-29976B3EACBFQ33836132-780AAC75-8F60-40D9-BB31-6057A710CA41Q34049548-9A081EA2-C6CB-4AAD-A725-B9FC1D2BA0B8Q34620134-954B810B-B37B-4672-BA20-A81905A815AAQ35034685-8C197286-6C37-4254-B7C2-712DF4F739CDQ35703690-7812BBC5-7BCA-4F10-BD32-63B446C52628Q36566081-41BACFC3-2CCA-4D6A-B066-C7FCD98387FDQ36872191-2F6CF914-4F63-4663-AB3A-B896B2DB3E99Q37300877-4CCF56F7-C5D9-43DF-AB85-D2D8A9E24570Q37610412-1E079B88-9BA4-44E0-B1EE-374387FC9977Q38219526-0B268404-2B0E-4393-B334-21ADA092CB11Q38669520-77D100FF-F7A3-475E-9629-5C7BBCD889CBQ38733745-A8B43F30-ED66-40E9-B51D-9F8279BD31BEQ41788304-11EE012B-0D59-40A4-A9E5-27639B56EE48Q51523923-6F92CD5A-94EF-42E9-A9F8-F4E18833C762
P2860
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Addition of inhaled long-actin ...... roid-naive adults and children
@ast
Addition of inhaled long-actin ...... roid-naive adults and children
@en
Addition of inhaled long-actin ...... roid-naive adults and children
@en-gb
Addition of inhaled long-actin ...... roid-naive adults and children
@nl
type
label
Addition of inhaled long-actin ...... roid-naive adults and children
@ast
Addition of inhaled long-actin ...... roid-naive adults and children
@en
Addition of inhaled long-actin ...... roid-naive adults and children
@en-gb
Addition of inhaled long-actin ...... roid-naive adults and children
@nl
prefLabel
Addition of inhaled long-actin ...... roid-naive adults and children
@ast
Addition of inhaled long-actin ...... roid-naive adults and children
@en
Addition of inhaled long-actin ...... roid-naive adults and children
@en-gb
Addition of inhaled long-actin ...... roid-naive adults and children
@nl
P2093
P2860
P3181
P1476
Addition of inhaled long-actin ...... roid-naive adults and children
@en
P2093
Ilana Greenstone
Muireann Ni Chroinin
Toby J Lasserson
P2860
P304
P3181
P356
10.1002/14651858.CD005307.PUB2
P407
P577
2009-01-01T00:00:00Z